Login / Signup

No evidence that CD33 splicing SNP impacts the response to GO in younger adults with AML treated on UK MRC/NCRI trials.

Rosemary E GaleTeodora PopaMelissa WrightNaeem KhanSylvie D FreemanAlan K BurnettNigel H RussellRobert K HillsDavid C Linch
Published in: Blood (2017)
Keyphrases
  • acute myeloid leukemia
  • genome wide
  • cross sectional
  • high density
  • allogeneic hematopoietic stem cell transplantation
  • nk cells
  • newly diagnosed
  • acute lymphoblastic leukemia